Quick Answer
PROCEPT BioRobotics Corp reported Net Income Loss of -$95.57 million for the year ending 2025.
- PROCEPT BioRobotics Corp showed a decrease of -4.5% in Net Income Loss from 2024 to 2025.
- This data is from PROCEPT BioRobotics Corp's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$13.13 million | Q2 2020: -$12.61 million | Q3 2020: -$12.01 million | Q1 2021: -$12.82 million | Q2 2021: -$14.58 million | Q3 2021: -$14.10 million | Q1 2022: -$17.19 million | Q2 2022: -$19.18 million | Q3 2022: -$22.61 million | Q1 2023: -$28.48 million | Q2 2023: -$25.29 million | Q3 2023: -$24.62 million | Q1 2024: -$25.96 million | Q2 2024: -$25.63 million | Q3 2024: -$20.97 million | Q1 2025: -$24.74 million | Q2 2025: -$19.58 million | Q3 2025: -$21.41 million.
- Over the full 6 years of available data (2020 to 2025), PROCEPT BioRobotics Corp's Net Income Loss has declined by 80.3%.
- Historical annual values: Fiscal year 2025: -$95.57 million | Fiscal year 2024: -$91.41 million | Fiscal year 2023: -$105.90 million | Fiscal year 2022: -$87.15 million | Fiscal year 2021: -$59.85 million | Fiscal year 2020: -$53.02 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: